With the globally active, therapy-focused healthcare company and Europe’s
largest private hospital operator Fresenius, another major player is investing in Avelios Medical and thus in the development of an open, interoperable, and AI-native digital healthcare ecosystem for Europe.
Avelios not only receives capital but also gains access to clinical practice experience from one of Europe’s largest private hospital networks. Fresenius Helios operates in around 140 clinics and outpatient facilities, serving approximately 27 million people annually according to the company.
Fresenius brings clinical processes into the Avelios platform
Fresenius will contribute real clinical requirements and best practices from various clinics to further develop the Avelios solution. This brings the scaling of the hospital information system (HIS) closer to clinical practice. The platform will be shaped not only by technology but also by standardized workflows from everyday clinical operations.
SAP had already made a strategic investment in Avelios in February 2026. The cloud-native HIS is to be operated on the SAP Business Technology Platform and will support AI, data management, and integration with SAP systems.
Strategic partnership for AI-native hospital IT in Europe
“We are bringing together what Germany and Europe need in healthcare: medical
excellence, technological strength, and the sovereign use of digitalization and AI. With our investment in Avelios Medical, we are taking another step in building a digital healthcare ecosystem – interoperable, reliable, and AI-enabled”,
says Chief Operating Officer of Fresenius Helios Christian Pawlu. And Christian Albrecht, co-founder and CEO of Avelios, adds:
“With SAP and Fresenius, we are bringing leading technological and clinical excellence to the table – and taking a crucial step toward an open ecosystem for the healthcare industry. The partnership validates our approach, our product, and our team.”
Why the AI-native HIS is strategically important
Hospital information systems are considered central infrastructure for digital healthcare. Avelios focuses on a structured data model, open standards, and interoperability. All of these are prerequisites for reliably deploying AI applications in clinical operations.
Fresenius describes the investment as a building block of a digital healthcare ecosystem; Avelios develops a modular HIS that digitalizes clinical and administrative processes and enables sovereign data use.
Who actually is Avelios Medical?
Avelios Medical was founded in 2020 in Munich by Christian Albrecht, Nicolas Jacob, and Dr. Sebastian Krammer. The idea originated from an AI research project at the LMU München. Today, the company positions itself as a provider of a modular, data-driven hospital information system.
For the Munich startup ecosystem, the deal is relevant because Avelios is binding two heavyweights from software and healthcare to its platform with SAP and Fresenius. According to its own statements, the startup remains independent, founder-led, and positioned to be open to industry partners.
